Latest

Registers› Irish medicines

Medicines register · Ireland

Every medicine authorised for the Irish market

The Health Products Regulatory Authority's full list of authorised products — brand, active substance, licence holder, licence number and market status. Filter it, cite it, and take it away as a file.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Abecma 260 - 500 x 106 cells dispersion for infusion EU/1/21/1539/001

Idecabtagene Vicleucel

Bristol-Myers Squibb Pharmaceuticals uc

—

Abraxane 5 mg/ml powder for dispersion for infusion EU/1/07/428/001

Paclitaxel

Bristol-Myers Squibb Pharma EEIG

—

AUGTYRO 160 mg hard capsules EU/1/24/1883/003-004

Repotrectinib

Bristol-Myers Squibb Pharma EEIG

—

AUGTYRO 40 mg hard capsules EU/1/24/1883/001-002

Repotrectinib

Bristol-Myers Squibb Pharma EEIG

—

Baraclude EU/1//06/343/01

Entecavir

Bristol-Myers Squibb Pharma EEIG

—

Baraclude 0.05 mg/ml oral solution EU/1/06/343/05

Entecavir

Bristol-Myers Squibb Pharma EEIG

—

Baraclude 0.5 mg film-coated tablets EU/1/06/343/001,3,6

Entecavir

Bristol-Myers Squibb Pharma EEIG

—

Baraclude 1 mg film-coated tablets EU/1/06/343/02,04,07

Entecavir

Bristol-Myers Squibb Pharma EEIG

—

Camzyos 10 mg Capsule hard EU/1/23/1716/005-006/011

Mavacamten

Bristol-Myers Squibb Pharma EEIG

—

Camzyos 15 mg Capsule hard EU/1/23/1716/007-008/012

Mavacamten

Bristol-Myers Squibb Pharma EEIG

—

Camzyos 2.5 mg Capsule hard EU/1/23/1716/001-002/009

Mavacamten

Bristol-Myers Squibb Pharma EEIG

—

Camzyos 5 mg Capsule hard EU/1/23/1716/003-004/010

Mavacamten

Bristol-Myers Squibb Pharma EEIG

—

CoAprovel 300 mg/25 mg film-coated tablets EU/1/98/086/023-028

Irbesartan, Hydrochlorothiazide

Sanofi Pharma Bristol-Myers Squibb SNC

—

Eliquis 0.15 mg granules in capsules for opening EU/1/11/691/016

Apixaban

Bristol-Myers Squibb/Pfizer EEIG

—

Eliquis 0.5 mg coated granule in sachet EU/1/11/691/017

Apixaban

Bristol-Myers Squibb/Pfizer EEIG

—

Eliquis 1.5 mg coated granule in sachet EU/1/11/691/018

Apixaban

Bristol-Myers Squibb/Pfizer EEIG

—

Eliquis 2 mg coated granule in sachet EU/1/11/691/019

Apixaban

Bristol-Myers Squibb/Pfizer EEIG

—

Eliquis 2.5 mg film-coated tablets EU/1/11/691/001-005, 013

Apixaban

Bristol-Myers Squibb Pharma EEIG

—

Eliquis 5 mg film-coated tablets EU/1/11/691/006-012

Apixaban

Bristol-Myers Squibb Pharma EEIG

—

Empliciti 300 mg powder for concentrate for solution for infusion. EU/1/16/1088/001

Elotuzumab

Bristol-Myers Squibb Pharma EEIG

—

Empliciti 400 mg powder for concentrate for solution for infusion. EU/1/16/1088/002

Elotuzumab

Bristol-Myers Squibb Pharma EEIG

—

EVOTAZ 300 mg/150 mg film-coated tablets EU/1/15/1025/001-002

Atazanavir, Cobicistat

Bristol-Myers Squibb Pharma EEIG

—

Furosemide Bristol 20 mg Tablets PA22749/001/001

Furosemide

Brillpharma (Ireland) Limited

Marketed

Furosemide Bristol 40 mg Tablets PA22749/001/002

Furosemide

Brillpharma (Ireland) Limited

Marketed

Imnovid 1 mg hard capsules EU/1/13/850/001

Pomalidomide

Bristol-Myers Squibb Pharma EEIG

—

Imnovid 2 mg hard capsules EU/1/13/850/002

Pomalidomide

Bristol-Myers Squibb Pharma EEIG

—

Imnovid 3 mg hard capsules EU/1/13/850/003

Pomalidomide

Bristol-Myers Squibb Pharma EEIG

—

Imnovid 4 mg hard capsules EU/1/13/850/004

Pomalidomide

Bristol-Myers Squibb Pharma EEIG

—

INREBIC 100 mg hard capsules EU/1/20/1514/001

Fedratinib dihydrochloride monohydrate, Fedratinib

Bristol-Myers Squibb Pharmaceuticals uc

—

Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg film-coated tablets EU/1/06/377/011-016

Irbesartan, Hydrochlorothiazide

Sanofi Pharma Bristol-Myers Squibb SNC

—

KRAZATI 200 mg film-coated tablets EU/1/23/1744/001-002

Adagrasib

Bristol-Myers Squibb Pharma EEIG

—

NULOJIX 250 mg powder for concentrate for solution for infusion EU/1/11/694/001-002

Belatacept

Bristol-Myers Squibb Pharma EEIG

—

OPDIVO 10 mg/mL concentrate for solution for infusion EU/1/15/1014/001-004

Nivolumab

Bristol-Myers Squibb Pharma EEIG

—

OPDIVO 300 mg solution for injection EU/1/15/1014/006

Nivolumab

Bristol-Myers Squibb Pharma EEIG

—

OPDIVO 600 mg solution for injection EU/1/15/1014/005

Nivolumab

Bristol-Myers Squibb Pharma EEIG

—

Opdualag 240 mg/80 mg sterile concentrate EU/1/22/1679/001

RELATLIMAB, Nivolumab

Bristol-Myers Squibb Pharma EEIG

—

Orencia 125 mg solution for injection in pre-filled pen EU/1/07/389/004-009

Abatacept

Bristol-Myers Squibb Pharma EEIG

—

Orencia 125 mg solution for injection in pre-filled pen EU/1/07/389/011-012

Abatacept

Bristol-Myers Squibb Pharma EEIG

—

Orencia 250 mg powder for concentrate for solution for infusion EU/1/07/389/1-3

Abatacept

Bristol-Myers Squibb Pharma EEIG

—

Orencia 50 mg solution for injection in pre-filled syringe EU/1/07/389/013

Abatacept

Bristol-Myers Squibb Pharma EEIG

—

Orencia 87.5 mg solution for injection in pre-filled syringe EU/1/07/389/014

Abatacept

Bristol-Myers Squibb Pharma EEIG

—

Reblozyl 25 mg powder for solution for injection EU/1/20/1452/001

Luspatercept

Bristol-Myers Squibb Pharma EEIG

—

Reblozyl 75 mg powder for solution for injection EU/1/20/1452/002

Luspatercept

Bristol-Myers Squibb Pharma EEIG

—

Revlimid 10 mg hard capsules EU/1/07/391/002

Lenalidomide

Bristol-Myers Squibb Pharma EEIG

—

Revlimid 15 mg hard capsules EU/1/07/391/003

Lenalidomide

Bristol-Myers Squibb Pharma EEIG

—

Revlimid 2.5 mg hard capsules EU/1/07/391/005

Lenalidomide

Bristol-Myers Squibb Pharma EEIG

—

Revlimid 20 mg hard capsules EU/1/07/391/009

Lenalidomide

Bristol-Myers Squibb Pharma EEIG

—

Revlimid 25 mg hard capsules EU/1/07/391/004

Lenalidomide

Bristol-Myers Squibb Pharma EEIG

—

Revlimid 5 mg hard capsules EU/1/07/391/001

Lenalidomide

Bristol-Myers Squibb Pharma EEIG

—

Revlimid 7.5 mg hard capsules EU/1/07/391/006

Lenalidomide

Bristol-Myers Squibb Pharma EEIG

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 28 September 2026. https://priyalifescience.com/medicines

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.